Cancer stem cells and their niche in cancer progression and therapy
2023 · Cancer Cell International · 51 citations
https://doi.org/10.1186/s12935-023-03130-2
X
Xiaoyan Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
173
Papers
4.4K
Citations
37
h-index
83
i10-index
Xiaoyan Li is an academic researcher from Ministry of Education of the People's Republic of China. The author has contributed to research in topics: Neutropenia and Cancer Infections & Cancer Immunotherapy and Biomarkers & Blood disorders and treatments. The author has an h-index of 37, co-authored 148 publications.
ORCID: 0000-0003-1910-2464Papers by this author
worksDiagnostic Value of Human Epididymis Protein 4 Compared with Mesothelin for Ovarian Cancer: a Systematic Review and Meta-analysis
2012 · Asian Pacific Journal of Cancer Prevention · 27 citations
https://doi.org/10.7314/apjcp.2012.13.11.5427
Reliability and validity of the Chinese version of the Family Resilience Questionnaire (FaRE Questionnaire) in patients with breast cancer: a cross-sectional study
2022 · BMJ Open · 19 citations
https://doi.org/10.1136/bmjopen-2021-051093
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
2015 · Supportive Care in Cancer · 14 citations
https://doi.org/10.1007/s00520-015-3039-4
Developing a deep learning-based imaging diagnostic framework, PVDNet, for differentiating pulmonary artery sarcoma and pulmonary thromboembolism: a multi-center observational study
2025 · The Lancet Regional Health - Western Pacific · 0 citations
https://doi.org/10.1016/j.lanwpc.2025.101625
CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: mechanistic insights and development of a CYP4B1-related prognostic signature
2026 · Frontiers in Oncology · 0 citations
https://doi.org/10.3389/fonc.2025.1661650
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat